What stage does Amplitude Venture Capital invest at?

Amplitude Venture Capital invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.

What sectors does Amplitude Venture Capital focus on?

Amplitude Venture Capital focuses on AI & Machine Learning, Biotech, Digital Health, Healthtech, Medical Devices.

Where is Amplitude Venture Capital located?

Amplitude Venture Capital is headquartered in Montreal, CA.

Does Amplitude Venture Capital lead rounds?

Amplitude Venture Capital typically participates in rounds rather than leading them.

Amplitude Venture Capital

Venture capital

Montreal · Seed–Late Stage · 16 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

✨ Fox Verdict

Investment thesis

Amplitude focuses on human health from ideation through patient care, specializing in precision medicine. As active company builders, entrepreneurs, and scientists, the firm partners with founders to create, build, and scale biotech and health science companies. It emphasizes excellence, transparency, and integrity, working closely with founders on strategy, talent, and fundraising. Amplitude also runs the Amplitude Fellowship, a summer program bringing Canadian health-focused PhD candidates, post-docs, and MDs together to explore biotech concepts and launch new health science companies.

Invests inAI & Machine Learning Biotech Digital Health Healthtech Medical DevicesCanadaGlobalMontrealNorth AmericaUnited States

Source: firm website, verified Aug 3, 2026.

Stage

Seed–Late Stage

Montreal, QC, CA

Leads rounds

Follows

Instruments

Equity

Founded

2018

AUM

$340M

Team · 16 people

from the firm's website & public directories

Matthew Rosenberger· Partner, CFO· Canadain

Partner and CFO at Amplitude, overseeing finance, legal, and administrative operations including due diligence and portfolio analysis. Previously Director of Finance at CoPower, a cleantech fund. Holds a BCom from McGill, a CPA, and is a CFA Charterholder.

Allison Gaw· Partnerin

Partner with 20 years of life science and drug development experience; previously VP of Business Development at Chinook Therapeutics and Senior Director at Sierra Oncology, and a consultant at BCG and LEK.

a•••@amplitudevc.comreveal

Bharat Srinivasa· Partner· Toronto, Ontarioin 𝕏

Co-founder and Partner at Amplitude (since 2018) with 15+ years in life sciences across VC, consulting, and biotech R&D; has co-founded three companies, two as founding CEO. Previously on the Healthcare Venture Fund investment team at BDC Capital. Holds a PhD and MSc in immunology from McGill and a BSc from the University of Toronto.

b•••@amplitudevc.comreveal

Dion Madsen· Partner· Canadain 𝕏

Co-founder and Managing Partner at Amplitude (since 2018) with a career spanning startups and public companies as executive and investor across life sciences, healthcare, and other sectors. Previously Senior Managing Partner of the Healthcare Venture Fund at BDC Capital and held roles at RBC Capital Partners and Unilever's US corporate venture fund.

d•••@amplitudevc.comreveal

Jean-François Pariseau· Managing Partner· Montrealin 𝕏

Managing Partner who co-founded Amplitude in 2018; a former scientist turned entrepreneur with 25+ years in biopharma, digital, and medtech, previously building the life sciences practice at BDC Capital and CDPQ.

j•••@amplitudevc.comreveal

Evelyn Pau· Principal· Toronto, Ontario, Canadain

Principal at Amplitude (joined August 2024), working with portfolio companies and Pre-Amp's Venture Studio while supporting diligence and deal nomination. Previously VP, Investment Banking at Bloom Burton & Co. Holds a PhD in immunology from the University of Toronto.

Michael Mee· Principal· Montrealin 𝕏

Partner at Amplitude (joined 2019) and Managing Director of Pre-Amp, the firm's incubation engine. Previously built platform companies at Flagship Pioneering. Holds a BEng from McGill and a PhD in biomedical engineering from Boston University.

m•••@amplitudevc.comreveal

Nancy Harrison· Venture Partner· Vancouver, BCin

Venture Partner who joined Amplitude in 2020, with over 30 years in life sciences and both company-creation and VC experience, previously a Partner at Ventures West and co-founder/president of MSI Methylation Sciences.

n•••@amplitudevc.comreveal

Colton Strong· Analyst· Vancouver, British Columbia, Canadain

Analyst at Amplitude who joined after the firm's Fellowship Program. His PhD at UBC pioneered lipid nanoparticles to genetically modify platelets as cell therapy; holds three patents with expertise in drug delivery and cell/gene therapies. Earned a BSc in Immunology from McGill.

Karen N. Li· Manager, Marketing and Communications· Toronto, Ontario, Canadain

Marketing and Communications Manager at Amplitude (joined October 2025), leading brand communications, creative assets, and events. Previously led communications and event production at Bloom Burton & Co. Holds an Honours BA from the University of Toronto.

k•••@amplitudevc.comreveal

Riccardo Cardilli· Finance Director· Montreal, Quebec, Canadain

Finance Director at Amplitude since 2022, focused on building financial and administrative infrastructure for early-stage biotech companies; previously Shared Services Controller at CellCarta Biosciences and a senior auditor at EY Montreal.

Ali Tehrani· Entrepreneur in Residence· Vancouver, British Columbia, Canadain

Entrepreneur in Residence at Amplitude (joined 2022). Co-founded Zymeworks Inc. and served as its President & CEO from 2003 to 2022, leading its NYSE IPO and multiple pharma partnerships. Holds BSc and MSc degrees from the University of Massachusetts and a doctorate from UBC.

a•••@amplitudevc.comreveal

Juliana Muñoz· Associate· Canadain 𝕏

j•••@amplitudevc.comreveal

Nadia Lachman· Investor· Calgary, Alberta, Canadain

Investor at Amplitude (joined 2024) with a background in retail pharmacy, clinical trial recruitment, and early-stage health startups across therapeutics, medical devices, and digital health, plus prior B2B SaaS venture investing. Holds a BSc, an MBT, and an MBA from the University of Calgary.

n•••@amplitudevc.comreveal

Allyson Tighe· Investor· Vancouver, BCin 𝕏

Anish Kaushal· Analyst· Canada𝕏

Frequently asked questions

What stage does Amplitude Venture Capital invest at?: Amplitude Venture Capital invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
What sectors does Amplitude Venture Capital focus on?: Amplitude Venture Capital focuses on AI & Machine Learning, Biotech, Digital Health, Healthtech, Medical Devices.
Where is Amplitude Venture Capital located?: Amplitude Venture Capital is headquartered in Montreal, CA.
Does Amplitude Venture Capital lead rounds?: Amplitude Venture Capital typically participates in rounds rather than leading them.

Images

Co-investors · 9

Venrock

Venrock is a venture capital firm investing across technology and healthcare, backing companies in fintech, developer infrastructure, life sciences, therapeutics, semiconductors, and consumer products.

$500K – $10M

OrbiMed

OrbiMed is a global healthcare-focused investment firm providing financing and operational support to companies across biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services.

$1M – $75M

BDC Venture Capital

BDC Venture Capital is the venture capital arm of the Business Development Bank of Canada, describing itself as Canada's largest and most active venture capital investor, backing Canadian technology companies with equity, advice and network access.

$365K – $25.6M

Dimension Capital

Dimension is a multistage investment firm that partners with companies working at the intersection of science and compute.

$1M – $10M

Versant Ventures

Versant Ventures operates in-house Discovery Engines staffed by multidisciplinary scientists in dedicated laboratory facilities to help launch new biotechnology companies alongside academic founders.

$250K – $5M

Domain Associates

Domain Associates (DomainVC) is a life sciences venture capital firm that served as investment advisors to the first VC fund dedicated to biotech and as investment manager of nine subsequent biotech VC funds.

$200K – $15M

Samsara BioCapital

Samsara BioCapital is an investment firm backing the development of transformative therapeutics for patients, bringing together scientists, physicians, drug developers, and business leaders to support next-generation therapeutic breakthroughs.

ShangBay Capital LLC

ShangBay Capital is a venture capital firm that invests in founders building disruptive companies addressing high, unmet clinical needs with novel ideas.

Pappas Capital

Pappas Capital is a life sciences venture capital firm that invests in and helps build companies developing next-generation life science products and technologies.

$100K – $6M

Firms observed investing alongside Amplitude Venture Capital, from public investor directories. Shared companies are the overlap with Amplitude Venture Capital's recorded portfolio.

Similar investors

Amadeus Capital Partners

Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.

$50K – $12.7M

B Capital Group

B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.

$10M – $50M

Capricorn Venture Partners

Capricorn Venture Partners is a European investment firm managing several thematic funds across growth capital, healthcare, and cleantech, as well as a combined private/quoted investment vehicle.

$270K – $10.8M

DCVC (Data Collective)

DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.

$5M – $25M

Foresite Capital

Foresite Capital is a multi-stage investment firm focused on healthcare and life sciences, backing companies across all stages of growth. It applies a data science-driven approach to invest in businesses leveraging biology and big data to transform healthcare.